Literature DB >> 15253918

Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors.

Kevin C Oeffinger1, Melissa M Hudson.   

Abstract

Survivors of childhood and adolescent cancer are one of the higher risk populations seen by health care professionals. The curative therapy administered for the cancer also affects growing and developing tissues. Following chemotherapy, radiation therapy, and surgery, many survivors will experience chronic or late-occurring health problems, often not becoming clinically apparent until decades after therapy. Survivors face an increased risk of morbidity, mortality, and diminished quality of life associated with their previous cancer therapy. Risk is further modified by the survivor's genetics, lifestyle habits, and comorbid health conditions. Over their lifetime, survivors will see health care professionals from an array of specialties and disciplines. The aim of this review is threefold: (1) to convey a sense of the risk faced by survivors to clinicians unfamiliar with the population; (2) to provide an up-to-date tool for clinicians, regardless of specialty or discipline, when providing care for a survivor; and (3) to complement the recently completed recommendations for screening, prevention, and management of childhood cancer survivors.

Entities:  

Mesh:

Year:  2004        PMID: 15253918     DOI: 10.3322/canjclin.54.4.208

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  96 in total

1.  Late effects in cancer survivors: “the shared care model”.

Authors:  Aziza Shad; Scott N Myers; Karen Hennessy
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

Review 2.  Endpoints in paediatric oncology.

Authors:  Paolo Paolucci; Vera Cioni; Elena Bigi; Laura Lucaccioni; Carmen Cano
Journal:  Eur J Clin Pharmacol       Date:  2010-11-18       Impact factor: 2.953

3.  Neurodevelopmental functioning in very young children undergoing treatment for non-CNS cancers.

Authors:  Marc H Bornstein; Sara Scrimin; Diane L Putnick; Fabia Capello; O Maurice Haynes; Simona de Falco; Modesto Carli; Marta Pillon
Journal:  J Pediatr Psychol       Date:  2012-02-02

Review 4.  Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.

Authors:  Emily S Tonorezos; Melissa M Hudson; Angela B Edgar; Leontien C Kremer; Charles A Sklar; W Hamish B Wallace; Kevin C Oeffinger
Journal:  Lancet Diabetes Endocrinol       Date:  2015-04-12       Impact factor: 32.069

5.  Cancer survivorship: the concept and the increasingly recognized reality.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

6.  Quality of life among parents of children with cancer or brain tumors: the impact of child characteristics and parental psychosocial factors.

Authors:  Kristin Litzelman; Kris Catrine; Ronald Gangnon; Whitney P Witt
Journal:  Qual Life Res       Date:  2011-02-02       Impact factor: 4.147

7.  Chronic conditions in adult survivors of childhood cancer.

Authors:  Robert J Wells
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

8.  Commentary: understanding risk behavior among adolescent cancer survivors--are they more like healthy adolescents or is cancer a teachable moment? A commentary on Klosky and colleagues' article on health behaviors in survivors of childhood cancer and their siblings.

Authors:  Stephanie M George; Ashley Wilder Smith
Journal:  J Pediatr Psychol       Date:  2012-05-13

Review 9.  Risk-based health monitoring of childhood cancer survivors: a report from the Children's Oncology Group.

Authors:  Susan B Nunez; Daniel A Mulrooney; Caroline Laverdiere; Melissa M Hudson
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

10.  Social outcomes in young adult survivors of low incidence childhood cancers.

Authors:  Inga M R Jóhannsdóttir; Marianne J Hjermstad; Torbjørn Moum; Finn Wesenberg; Lars Hjorth; Henrik Schrøder; Päivi Lähteenmäki; Gudmundur Jónmundsson; Jon H Loge
Journal:  J Cancer Surviv       Date:  2010-01-16       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.